Logo image of MELE.BR

MELEXIS NV (MELE.BR) Stock Fundamental Analysis

Europe - Euronext Brussels - EBR:MELE - BE0165385973 - Common Stock

62 EUR
+1.45 (+2.39%)
Last: 1/6/2026, 7:00:00 PM
Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to MELE. MELE was compared to 65 industry peers in the Semiconductors & Semiconductor Equipment industry. While MELE has a great profitability rating, there are some minor concerns on its financial health. MELE is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

In the past year MELE was profitable.
In the past year MELE had a positive cash flow from operations.
Each year in the past 5 years MELE has been profitable.
Each year in the past 5 years MELE had a positive operating cash flow.
MELE.BR Yearly Net Income VS EBIT VS OCF VS FCFMELE.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M

1.2 Ratios

MELE's Return On Assets of 14.20% is fine compared to the rest of the industry. MELE outperforms 80.00% of its industry peers.
MELE's Return On Equity of 25.94% is fine compared to the rest of the industry. MELE outperforms 72.31% of its industry peers.
MELE has a better Return On Invested Capital (15.69%) than 75.38% of its industry peers.
The Average Return On Invested Capital over the past 3 years for MELE is significantly above the industry average of 15.03%.
The 3 year average ROIC (31.03%) for MELE is well above the current ROIC(15.69%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 14.2%
ROE 25.94%
ROIC 15.69%
ROA(3y)25.78%
ROA(5y)24.35%
ROE(3y)36.37%
ROE(5y)32.97%
ROIC(3y)31.03%
ROIC(5y)28.48%
MELE.BR Yearly ROA, ROE, ROICMELE.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

1.3 Margins

MELE has a Profit Margin of 15.42%. This is comparable to the rest of the industry: MELE outperforms 56.92% of its industry peers.
MELE's Profit Margin has improved in the last couple of years.
MELE has a Operating Margin of 18.29%. This is comparable to the rest of the industry: MELE outperforms 52.31% of its industry peers.
MELE's Operating Margin has improved in the last couple of years.
MELE's Gross Margin of 40.24% is on the low side compared to the rest of the industry. MELE is outperformed by 66.15% of its industry peers.
In the last couple of years the Gross Margin of MELE has grown nicely.
Industry RankSector Rank
OM 18.29%
PM (TTM) 15.42%
GM 40.24%
OM growth 3Y0.51%
OM growth 5Y8.98%
PM growth 3Y-3.36%
PM growth 5Y8.23%
GM growth 3Y0.09%
GM growth 5Y1.54%
MELE.BR Yearly Profit, Operating, Gross MarginsMELE.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

6

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), MELE is creating value.
MELE has about the same amout of shares outstanding than it did 1 year ago.
Compared to 5 years ago, MELE has more shares outstanding
Compared to 1 year ago, MELE has a worse debt to assets ratio.
MELE.BR Yearly Shares OutstandingMELE.BR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
MELE.BR Yearly Total Debt VS Total AssetsMELE.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

MELE has an Altman-Z score of 6.38. This indicates that MELE is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 6.38, MELE is in line with its industry, outperforming 52.31% of the companies in the same industry.
MELE has a debt to FCF ratio of 3.48. This is a good value and a sign of high solvency as MELE would need 3.48 years to pay back of all of its debts.
The Debt to FCF ratio of MELE (3.48) is comparable to the rest of the industry.
A Debt/Equity ratio of 0.62 indicates that MELE is somewhat dependend on debt financing.
MELE has a worse Debt to Equity ratio (0.62) than 75.38% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.62
Debt/FCF 3.48
Altman-Z 6.38
ROIC/WACC1.43
WACC10.95%
MELE.BR Yearly LT Debt VS Equity VS FCFMELE.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M

2.3 Liquidity

MELE has a Current Ratio of 5.59. This indicates that MELE is financially healthy and has no problem in meeting its short term obligations.
MELE has a Current ratio of 5.59. This is amongst the best in the industry. MELE outperforms 93.85% of its industry peers.
A Quick Ratio of 2.71 indicates that MELE has no problem at all paying its short term obligations.
MELE's Quick ratio of 2.71 is amongst the best of the industry. MELE outperforms 83.08% of its industry peers.
Industry RankSector Rank
Current Ratio 5.59
Quick Ratio 2.71
MELE.BR Yearly Current Assets VS Current LiabilitesMELE.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

4

3. Growth

3.1 Past

The earnings per share for MELE have decreased strongly by -46.51% in the last year.
MELE shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 23.04% yearly.
MELE shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -16.57%.
MELE shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 13.89% yearly.
EPS 1Y (TTM)-46.51%
EPS 3Y9.29%
EPS 5Y23.04%
EPS Q2Q%-46.03%
Revenue 1Y (TTM)-16.57%
Revenue growth 3Y13.16%
Revenue growth 5Y13.89%
Sales Q2Q%-13.14%

3.2 Future

Based on estimates for the next years, MELE will show a small growth in Earnings Per Share. The EPS will grow by 7.41% on average per year.
The Revenue is expected to grow by 5.53% on average over the next years.
EPS Next Y-29.28%
EPS Next 2Y-8.34%
EPS Next 3Y1.48%
EPS Next 5Y7.41%
Revenue Next Year-10.45%
Revenue Next 2Y-1.26%
Revenue Next 3Y2.16%
Revenue Next 5Y5.53%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
MELE.BR Yearly Revenue VS EstimatesMELE.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 500M 1B
MELE.BR Yearly EPS VS EstimatesMELE.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2 4 6

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 23.13, which indicates a rather expensive current valuation of MELE.
Based on the Price/Earnings ratio, MELE is valued a bit cheaper than 80.00% of the companies in the same industry.
MELE's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 27.17.
MELE is valuated rather expensively with a Price/Forward Earnings ratio of 17.45.
Compared to the rest of the industry, the Price/Forward Earnings ratio of MELE indicates a somewhat cheap valuation: MELE is cheaper than 80.00% of the companies listed in the same industry.
MELE is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 23.79, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 23.13
Fwd PE 17.45
MELE.BR Price Earnings VS Forward Price EarningsMELE.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

MELE's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. MELE is cheaper than 78.46% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, MELE is valued cheaper than 87.69% of the companies in the same industry.
Industry RankSector Rank
P/FCF 27.1
EV/EBITDA 13.19
MELE.BR Per share dataMELE.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

MELE has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)1
EPS Next 2Y-8.34%
EPS Next 3Y1.48%

4

5. Dividend

5.1 Amount

MELE has a Yearly Dividend Yield of 2.26%.
MELE's Dividend Yield is rather good when compared to the industry average which is at 0.81. MELE pays more dividend than 90.77% of the companies in the same industry.
MELE's Dividend Yield is comparable with the S&P500 average which is at 1.94.
Industry RankSector Rank
Dividend Yield 2.26%

5.2 History

The dividend of MELE is nicely growing with an annual growth rate of 10.98%!
Dividend Growth(5Y)10.98%
Div Incr Years3
Div Non Decr Years6
MELE.BR Yearly Dividends per shareMELE.BR Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 2025 1 2 3

5.3 Sustainability

MELE pays out 112.64% of its income as dividend. This is not a sustainable payout ratio.
MELE's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP112.64%
EPS Next 2Y-8.34%
EPS Next 3Y1.48%
MELE.BR Yearly Income VS Free CF VS DividendMELE.BR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M
MELE.BR Dividend Payout.MELE.BR Dividend Payout, showing the Payout Ratio.MELE.BR Dividend Payout.PayoutRetained Earnings

MELEXIS NV

EBR:MELE (1/6/2026, 7:00:00 PM)

62

+1.45 (+2.39%)

Chartmill FA Rating
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)10-29 2025-10-29/bmo
Earnings (Next)02-04 2026-02-04/amc
Inst Owners15.3%
Inst Owner ChangeN/A
Ins Owners25%
Ins Owner ChangeN/A
Market Cap2.50B
Revenue(TTM)822.53M
Net Income(TTM)131.83M
Analysts75.79
Price Target72.18 (16.42%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.26%
Yearly Dividend3.7
Dividend Growth(5Y)10.98%
DP112.64%
Div Incr Years3
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)19.96%
Min EPS beat(2)-2.47%
Max EPS beat(2)42.38%
EPS beat(4)1
Avg EPS beat(4)-0.06%
Min EPS beat(4)-38.45%
Max EPS beat(4)42.38%
EPS beat(8)3
Avg EPS beat(8)-0.67%
EPS beat(12)6
Avg EPS beat(12)0.27%
EPS beat(16)10
Avg EPS beat(16)4.23%
Revenue beat(2)1
Avg Revenue beat(2)0.71%
Min Revenue beat(2)-1.87%
Max Revenue beat(2)3.28%
Revenue beat(4)1
Avg Revenue beat(4)-1.66%
Min Revenue beat(4)-5.22%
Max Revenue beat(4)3.28%
Revenue beat(8)1
Avg Revenue beat(8)-1.74%
Revenue beat(12)3
Avg Revenue beat(12)-1.22%
Revenue beat(16)6
Avg Revenue beat(16)-0.6%
PT rev (1m)-4.69%
PT rev (3m)-6.66%
EPS NQ rev (1m)0%
EPS NQ rev (3m)1.46%
EPS NY rev (1m)0%
EPS NY rev (3m)-0.02%
Revenue NQ rev (1m)0.44%
Revenue NQ rev (3m)0.75%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.05%
Valuation
Industry RankSector Rank
PE 23.13
Fwd PE 17.45
P/S 2.93
P/FCF 27.1
P/OCF 19
P/B 4.93
P/tB 4.94
EV/EBITDA 13.19
EPS(TTM)2.68
EY4.32%
EPS(NY)3.55
Fwd EY5.73%
FCF(TTM)2.29
FCFY3.69%
OCF(TTM)3.26
OCFY5.26%
SpS21.17
BVpS12.58
TBVpS12.55
PEG (NY)N/A
PEG (5Y)1
Graham Number27.54
Profitability
Industry RankSector Rank
ROA 14.2%
ROE 25.94%
ROCE 18.88%
ROIC 15.69%
ROICexc 16.36%
ROICexgc 16.39%
OM 18.29%
PM (TTM) 15.42%
GM 40.24%
FCFM 10.81%
ROA(3y)25.78%
ROA(5y)24.35%
ROE(3y)36.37%
ROE(5y)32.97%
ROIC(3y)31.03%
ROIC(5y)28.48%
ROICexc(3y)38.83%
ROICexc(5y)36.08%
ROICexgc(3y)39.06%
ROICexgc(5y)36.42%
ROCE(3y)37.33%
ROCE(5y)34.27%
ROICexgc growth 3Y-14.81%
ROICexgc growth 5Y1.87%
ROICexc growth 3Y-14.47%
ROICexc growth 5Y2.21%
OM growth 3Y0.51%
OM growth 5Y8.98%
PM growth 3Y-3.36%
PM growth 5Y8.23%
GM growth 3Y0.09%
GM growth 5Y1.54%
F-Score4
Asset Turnover0.92
Health
Industry RankSector Rank
Debt/Equity 0.62
Debt/FCF 3.48
Debt/EBITDA 1.52
Cap/Depr 77.5%
Cap/Sales 4.61%
Interest Coverage 14.77
Cash Conversion 63.61%
Profit Quality 70.12%
Current Ratio 5.59
Quick Ratio 2.71
Altman-Z 6.38
F-Score4
WACC10.95%
ROIC/WACC1.43
Cap/Depr(3y)136.47%
Cap/Depr(5y)110.04%
Cap/Sales(3y)6.76%
Cap/Sales(5y)6.25%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-46.51%
EPS 3Y9.29%
EPS 5Y23.04%
EPS Q2Q%-46.03%
EPS Next Y-29.28%
EPS Next 2Y-8.34%
EPS Next 3Y1.48%
EPS Next 5Y7.41%
Revenue 1Y (TTM)-16.57%
Revenue growth 3Y13.16%
Revenue growth 5Y13.89%
Sales Q2Q%-13.14%
Revenue Next Year-10.45%
Revenue Next 2Y-1.26%
Revenue Next 3Y2.16%
Revenue Next 5Y5.53%
EBIT growth 1Y-40.01%
EBIT growth 3Y13.74%
EBIT growth 5Y24.11%
EBIT Next Year-16.89%
EBIT Next 3Y5.62%
EBIT Next 5Y7.46%
FCF growth 1Y533.33%
FCF growth 3Y6.64%
FCF growth 5Y13.04%
OCF growth 1Y213.78%
OCF growth 3Y7.8%
OCF growth 5Y13.55%

MELEXIS NV / MELE.BR FAQ

What is the ChartMill fundamental rating of MELEXIS NV (MELE.BR) stock?

ChartMill assigns a fundamental rating of 6 / 10 to MELE.BR.


What is the valuation status of MELEXIS NV (MELE.BR) stock?

ChartMill assigns a valuation rating of 5 / 10 to MELEXIS NV (MELE.BR). This can be considered as Fairly Valued.


How profitable is MELEXIS NV (MELE.BR) stock?

MELEXIS NV (MELE.BR) has a profitability rating of 7 / 10.


What is the valuation of MELEXIS NV based on its PE and PB ratios?

The Price/Earnings (PE) ratio for MELEXIS NV (MELE.BR) is 23.13 and the Price/Book (PB) ratio is 4.93.


What is the expected EPS growth for MELEXIS NV (MELE.BR) stock?

The Earnings per Share (EPS) of MELEXIS NV (MELE.BR) is expected to decline by -29.28% in the next year.